𧬠ICD-10-CM G25.0 β Essential Tremor
Billable Code Confirmed
ICD-10-CM G25.0 is a valid, billable 3-character ICD-10-CM code for FY2026. No further character subdivision is required β
G25.0is the complete, billable code. Classified under G25 β Other Extrapyramidal and Movement Disorders, within the G20-G26 Extrapyramidal and Movement Disorders block. The ICD-10-CM Tabular List includes Familial tremor as an official Includes term under G25.0.
G25.0 vs. R25.1 β Confirmed Diagnosis vs. Symptom Code
G25.0 (Essential tremor β confirmed diagnosis) and R25.1 (Tremor, unspecified β symptom code) are Excludes1 β mutually exclusive. They represent two different stages of diagnostic certainty:
- R25.1 = Tremor observed but not yet classified; unspecified; etiology undetermined; appropriate at the initial evaluation or while workup is pending
- G25.0 = Essential tremor confirmed and documented by the physician based on clinical criteria; replaces R25.1 once ET is established
Once the physician has documented βessential tremorβ β do NOT continue to assign R25.1. The Excludes1 relationship means they CANNOT appear on the same encounter. Per ICD-10-CM guidelines and Pabauβs March 2026 coding guidance: βWhen examination reveals essential tremor characteristics β bilateral, action-induced, and responsive to alcohol β G25.0 must replace R25.1.β
G25.0 vs. G20.x β Essential Tremor vs. Parkinson's Disease Rest Tremor
G25.0 (essential tremor) and the G20.x Parkinsonβs disease subcodes are clinically and coding-distinct and are Excludes1 β mutually exclusive under their respective categories. The resting tremor of Parkinsonβs disease is NOT essential tremor and must NEVER be coded as G25.0:
Feature Essential Tremor (G25.0) PD Rest Tremor (G20.x) Tremor type Action (postural + kinetic) Rest tremor β classic pill-rolling Timing Occurs with voluntary movement or sustained posture Present at rest; improves with action Body distribution Bilateral hands > head > voice; symmetric Unilateral onset; asymmetric; pill-rolling quality Family history Present in 50-70% Not a defining feature Alcohol response Classically reduces tremor (~50%) Little to no effect Associated signs None (pure tremor disorder) Bradykinesia, rigidity, micrographia DaTscan NORMAL Abnormal (reduced DaT uptake) Levodopa response None Robust and diagnostic HCC mapping NOT HCC-mapped HCC 155 (Parkinsonβs Disease and Huntingtonβs Disease) Clinical overlap note: Some patients have both ET AND early PD β termed ET-PD in the MDS consensus classification. When both conditions are separately documented by the physician, G25.0 AND the appropriate G20.x subcode may be coded simultaneously as SEPARATE coexisting conditions (they are NOT Excludes1 to each other directly β the exclusion is specific to coding PD rest tremor AS G25.0). A CDI query is appropriate when documentation is ambiguous.
Code Classification
ICD-10-CM Diagnosis Code β standalone etiology code with no mandatory companion codes. No βcode alsoβ or βuse additional codeβ instruction exists at G25.0 in the FY2026 Tabular List. Essential tremor is not part of an etiology/manifestation pair. For botulinum toxin injection medical necessity (essential head/voice tremor), G25.0 directly supports CPT 64617 and 64616 injection codes without additional companion codes required.
π Code Description
ICD-10-CM G25.0 classifies essential tremor (ET) β the most common movement disorder in clinical practice, affecting an estimated 5-10% of the population over age 60 and up to 20% of those over 80, making it by far the most prevalent neurological cause of tremor worldwide. ET is characterized by a bilateral, rhythmic, action tremor (occurring with voluntary movement and/or sustained posture) that most commonly affects the upper limbs, followed by the head, voice, jaw, and less commonly the lower limbs. The tremor frequency typically ranges from 4-12 Hz, with the most common presentation being a 6-8 Hz postural and kinetic hand tremor that interferes with handwriting, eating, drinking, and fine motor tasks.
The etiology of ET is multifactorial β approximately 50-70% of cases are familial, with autosomal dominant inheritance and incomplete penetrance (hence the official Includes term βFamilial tremorβ in the ICD-10-CM Tabular under G25.0). The remaining cases are sporadic with no identified genetic or environmental cause. Multiple chromosomal loci (ETM1, ETM2, ETM3) and candidate genes have been identified, but no single causative mutation explains the majority of cases β ET likely represents a heterogeneous syndrome rather than a single disease entity.
Despite its historical designation as βbenign essential tremor,β ET is not uniformly benign. Disability from ET is significant in 25-30% of patients β interfering with activities of daily living including writing, eating, drinking, and occupational tasks. The condition is slowly progressive over decades, with worsening amplitude over time, gradual spread from hands to head/voice/trunk, and in a subset of patients, development of mild cerebellar features (ET-plus) or evolution toward ET-PD overlap. The strong, predictable temporary improvement with modest alcohol consumption (approximately 50% of patients) is one of the most characteristic and clinically confirmatory features of ET and should be documented when present, as it supports the diagnosis.
π³ Code Tree / Hierarchy
G20-G26 Extrapyramidal and Movement Disorders
β
βββ G20 β Parkinson's Disease (Idiopathic)
β βββ [G20.A1, G20.A2, G20.B1, G20.B2, G20.C1 β see G20 notes]
β
βββ G21 β Secondary Parkinsonism
β βββ [G21.11, G21.19, G21.4, G21.9 β see G21 notes]
β
βββ G24 β Dystonia
β βββ G24.01 β Drug induced subacute dyskinesia β
Billable
β βββ G24.02 β Drug induced acute dystonia β
Billable
β βββ G24.1 β Genetic torsion dystonia β
Billable [Excludes1 from G25]
β βββ G24.3 β Spasmodic torticollis β
Billable
β
βββ G25 β Other Extrapyramidal and Movement Disorders β Non-billable header
β β [Excludes1 at G25 category: genetic torsion dystonia (G24.1);
β β abnormal head movements (R25.0)]
β β
β βββ G25.0 β Essential tremor β THIS CODE β
Billable
β β [Includes: Familial tremor]
β β [Excludes1: tremor NOS (R25.1)]
β βββ G25.1 β Drug-induced tremor β
Billable
β β [Use additional code for adverse effect T36-T50.x5]
β βββ G25.2 β Other specified forms of tremor β
Billable
β β [Includes: intention tremor of cerebellar disease]
β βββ G25.3 β Myoclonus β
Billable
β βββ G25.4 β Drug-induced chorea β
Billable
β βββ G25.5 β Other chorea β
Billable
β βββ G25.61 β Periodic limb movement disorder β
Billable
β βββ G25.69 β Other sleep related movement disorders β
Billable
β βββ G25.70 β Drug induced movement disorder, unspecified β
Billable
β βββ G25.71 β Drug induced akathisia β
Billable
β βββ G25.79 β Other drug induced movement disorders β
Billable
β βββ G25.81 β Restless legs syndrome β
Billable
β βββ G25.82 β Stiff-man syndrome β
Billable
β βββ G25.83 β Benign shuddering attacks β
Billable
β βββ G25.89 β Other specified extrapyramidal and movement disorders β
Billable
β
βββ G26 β Extrapyramidal and movement disorders in diseases elsewhere β
Billable
G25.0 Is the Most Common Code in the Entire G20-G26 Block
Essential tremor is estimated to affect 10 million Americans β more patients than all other movement disorders combined, including Parkinsonβs disease. G25.0 is therefore statistically the most frequently assigned code in the entire G20-G26 extrapyramidal and movement disorders block. Accuracy in distinguishing G25.0 from G20.x (Parkinsonβs) and R25.1 (unspecified tremor) is among the highest-volume coding decisions in neurology and primary care.
β Includes
The following clinical terms and scenarios map to G25.0 when the physician explicitly documents essential tremor:
- Essential tremor β the standard physician documentation term
- Familial tremor β official ICD-10-CM Includes term at G25.0; autosomal dominant hereditary tremor
- Benign essential tremor β historical synonym; maps to G25.0
- Senile tremor β when physician applies this term to an age-related action tremor with ET characteristics
- Essential tremor of the hands β the most common presentation
- Essential tremor of the head (titubation) β cervical/cephalic tremor; head nodding (βyes-yesβ) or rotational (βno-noβ) pattern
- Essential voice tremor β tremulous voice from laryngeal ET; may require separate otolaryngology/SLP management
- Essential tremor with family history (familial ET subtype)
- Essential tremor, sporadic β physician documents ET without family history
Physician Must Diagnose ET β Coder Cannot Assign G25.0 from Symptoms Alone
G25.0 is a confirmed diagnosis code β it requires explicit physician documentation of βessential tremorβ or a recognized synonym (familial tremor, benign essential tremor). A coder may NOT assign G25.0 simply because a patient has bilateral hand tremor described in the visit note without a physician-stated diagnosis of ET. When tremor is documented but ET is not yet confirmed β assign R25.1 (tremor, unspecified) and flag for CDI query at follow-up once ET is established.
β Excludes
Excludes 1 β Cannot Be Coded Simultaneously with G25.0
| Code | Description | Note |
|---|---|---|
| R25.1 | Tremor, unspecified | Mutually exclusive β R25.1 is replaced by G25.0 once ET is confirmed and documented; do not code both |
| G25.1 | Drug-induced tremor | Mutually exclusive β tremor caused by a medication (valproate, lithium, SSRIs, amiodarone, beta-agonists) that began after drug initiation requires G25.1 + T-code; a patient with pre-existing confirmed ET who also starts a tremorgenic drug and has worsening tremor requires physician attribution before code selection |
| G25.2 | Other specified forms of tremor (intention tremor) | Mutually exclusive β intention tremor (worsens at end of goal-directed movement) is a cerebellar sign coded to G25.2, NOT G25.0 |
| R25.0 | Abnormal head movements | Excludes1 from G25 category level |
| G24.1 | Genetic torsion dystonia | Excludes1 from G25 category level β dystonic tremor, a tremor associated with focal dystonia, is NOT ET; requires G24.x coding |
The ET vs. Dystonic Tremor Distinction
Dystonic tremor β tremor occurring in a body part affected by dystonia (e.g., torticollis with head tremor, writerβs cramp with hand tremor) β is NOT essential tremor and should NOT be coded as G25.0. Dystonic tremor maps to the G24.x dystonia codes. When a patient presents with head tremor or hand tremor and also has abnormal posturing or dystonic features, the physician must clarify whether the tremor is essential tremor (G25.0) or dystonic tremor (G24.x). This distinction also determines treatment: botulinum toxin injection for dystonic tremor uses 64616/64617 for ET-related voice tremor, but cervical dystonia + head tremor would use 64616 (chemodenervation of neck muscle) β the etiology drives the treatment code selection.
ET-Plus and ET-PD β When Multiple Codes Apply
The MDS (Movement Disorder Society) 2018 classification introduced two related categories:
- ET-plus: ET with additional neurological signs (mild ataxia, resting tremor, mild cognitive impairment) that are not sufficient to diagnose a specific disease β still codes to G25.0 as the primary diagnosis; additional signs are coded separately when documented
- ET-PD: Patient meets criteria for BOTH essential tremor AND Parkinsonβs disease β both G25.0 AND the appropriate G20.x subcode may be coded when both are explicitly documented by the physician as separate coexisting diagnoses
π Clinical Overview
Diagnostic Criteria β What Supports G25.0 Assignment
The diagnosis of essential tremor is clinical β based on history, neurological examination, and exclusion of alternative etiologies. There is no single biomarker. The following documentation elements support G25.0 assignment and medical necessity for treatment:
| Documentation Element | Clinical Detail | Coding Relevance |
|---|---|---|
| Bilateral action tremor | Postural (sustained position against gravity) and/or kinetic (during voluntary movement); usually hands | Core diagnostic criterion β must be bilateral by definition |
| Duration | Typically >3 years for definitive diagnosis; ET is slowly progressive | Chronicity documentation supports ET over drug-induced or physiologic tremor |
| Family history | Positive in 50-70%; autosomal dominant pattern | Maps to βFamilial tremorβ β Includes term at G25.0 |
| Alcohol responsiveness | ~50% of ET patients report tremor improvement with small amounts of alcohol | Highly specific for ET; document when patient reports this feature |
| Frequency | 6-12 Hz (most commonly 6-8 Hz hand tremor) | Physiologic/exaggerated physiologic tremor is 8-12 Hz; cerebellar tremor is 3-5 Hz |
| Absence of other neurological signs | No bradykinesia, rigidity, micrographia, dystonia, cerebellar ataxia | Exclusion of PD, dystonia, cerebellar disease |
| Normal DaTscan | When performed β essential tremor does NOT reduce dopamine transporter availability | Critical differentiator from PD; normal DaTscan strongly supports ET over PD |
| Functional impact | Difficulty writing, eating, drinking; occupational impairment; social embarrassment | Required for advanced therapy medical necessity (DBS, MRgFUS); supports higher E/M complexity |
ET Body Distribution and Clinical Variants
| Body Area | Prevalence | Clinical Features | Treatment Implication |
|---|---|---|---|
| Hands/upper limbs | >95% | Bilateral postural + kinetic tremor; impairs writing, eating, fine motor tasks | Propranolol, primidone; DBS; MRgFUS |
| Head (titubation) | 30-40% | βYes-yesβ (flexion-extension) or βno-noβ (rotation) head oscillation; usually WITHOUT neck pain | Propranolol; botulinum toxin injection β head tremor specific to neck muscles |
| Voice (laryngeal) | 10-20% | Tremulous, quavering voice; vocal fluctuation; may be socially disabling; often underdiagnosed | Botulinum toxin β 64617 (vocal cord); propranolol; primidone |
| Trunk | 5-10% | Trunk oscillation; worsens with standing; can impair gait | Often part of more advanced disease; DBS |
| Jaw/perioral | <5% | Jaw tremor; perioral quivering | Differentiate from PD perioral tremor (βrabbit syndromeβ) |
| Lower limbs | <5% | Leg tremor; uncommon in pure ET; when present, consider ET-plus or ET-PD overlap | Query physician for G25.0 vs. G20.x |
Essential Voice Tremor β An Underdiagnosed G25.0 Variant With Distinct CPT Coding
Essential voice tremor is a clinically distinct and frequently underdiagnosed presentation of G25.0 where the primary or sole manifestation is a tremulous, quavering voice from laryngeal/pharyngeal muscle involvement. It is commonly managed by otolaryngology/laryngology in addition to neurology and supports:
- 64617 β Chemodenervation of larynx (botulinum toxin β thyroarytenoid muscle injection for essential voice tremor) β the primary procedural treatment for disabling essential voice tremor
- 31575 β Diagnostic laryngoscopy (flexible, for visualization of vocal cord tremor prior to injection)
Documentation must specify βessential voice tremorβ or βlaryngeal essential tremorβ β distinguish from spasmodic dysphonia (G24.3 or F44.4) which maps to different codes and requires different injection targeting.
Treatment Ladder for G25.0 Medical Necessity
| Treatment Tier | Agent / Procedure | CPT/Code | Medical Necessity Criteria |
|---|---|---|---|
| Tier 1 β First-line pharmacotherapy | Propranolol (non-selective beta-blocker) | Medication management under E/M | Tremor confirmed by physician; functional impairment documented |
| Tier 1 β First-line pharmacotherapy | Primidone (anticonvulsant) | Medication management under E/M | Alternative first-line; useful when propranolol contraindicated (asthma, COPD, bradycardia) |
| Tier 2 β Second-line pharmacotherapy | Topiramate, gabapentin, alprazolam, atenolol | Medication management under E/M | Failure of first-line agents documented |
| Tier 3 β Botulinum toxin injection | OnabotulinumtoxinA (Botox) / RimabotulinumtoxinB (Myobloc) | 64617 (larynx/voice), 64616 (neck for head tremor), 64616 / 64642 (hand/forearm) | Disabling voice or head tremor; failure or intolerance of pharmacotherapy |
| Tier 4 β Focused ultrasound thalamotomy | MRI-guided High Intensity Focused Ultrasound (MRgFUS) β unilateral VIM thalamotomy | 61715 | Medication-refractory ET affecting hand tremor; FDA-approved; non-invasive; unilateral only per current guidelines |
| Tier 4 β Deep brain stimulation | Thalamic VIM DBS (bilateral possible) | 61885 / 61886 (IPG); 95983 / 95984 (programming) | Disabling, medication-refractory tremor; bilateral upper limb involvement; preference for reversible procedure |
| Tier 4 β Radiosurgery | Gamma Knife thalamotomy (stereotactic radiosurgery) | 61796 | Medication-refractory; patient not a DBS candidate (anticoagulation, surgical risk) |
MRgFUS CPT 61715 β Coverage and Documentation Requirements (2026)
CPT 61715 (stereotactic radiosurgical procedure β thalamic/subthalamic target) is used for MRgFUS unilateral VIM thalamotomy for essential tremor. G25.0 is the primary ICD-10-CM code supporting medical necessity. As of January 1, 2026, NYS Medicaid covers MRgFUS for medication-refractory ET (MetroPlusHealth policy, effective January 2026). CMS Medicare coverage requires documentation of: (1) confirmed ET (G25.0) affecting upper limb(s); (2) failure of at least two pharmacological agents (propranolol, primidone, topiramate); (3) significant functional disability; (4) MRI eligibility. MRgFUS is FDA-approved for UNILATERAL thalamotomy only β bilateral procedures are not currently FDA-cleared for ET.
Pathophysiology
The neuroanatomical substrate of essential tremor remains incompletely understood, but converging evidence from imaging, electrophysiology, and pathological studies points to dysfunction within the cerebello-thalamo-cortical loop as the primary driver. The cerebellum β particularly the inferior olive, cerebellar cortex (Purkinje cells), and dentate nucleus β shows reduced GABAergic inhibitory activity, producing pathological rhythmic oscillations that propagate via the thalamus (ventral intermediate nucleus, VIM) to the motor cortex. This is why VIM thalamus is the surgical target for both DBS and MRgFUS in ET β disrupting or modulating the thalamic relay point of the oscillatory loop reliably suppresses tremor. This cerebellar origin also explains why ET is an action tremor (activated during voluntary movement) rather than a rest tremor (which is basal ganglia/dopaminergic in origin, as in PD).
π° HCC Risk Adjustment (CMS-HCC v28)
| Field | Detail |
|---|---|
| CMS-HCC Model Version | v28 (100% Implementation FY2026) |
| HCC Assignment | β NOT MAPPED β G25.0 does not map to any CMS-HCC v28 category |
| RAF Contribution | Zero direct RAF contribution from G25.0 |
| Clinical Implication | G25.0 does not affect Medicare Advantage risk score; HCC value at ET encounters comes entirely from comorbid conditions |
G25.0 Has No HCC Value β But Comorbidities at ET Encounters Do
Because G25.0 is NOT an HCC-mapped code, its submission generates no RAF benefit for Medicare Advantage. However, the typical ET patient population β older adults with significant medical comorbidity β presents substantial compound HCC capture opportunities at every ET encounter that must not be overlooked:
Common comorbidities at G25.0 encounters with HCC value:
- Hypertension (I10) β most prevalent comorbidity in ET age group; critical to monitor when propranolol is prescribed (propranolol also treats hypertension β dual documentation value)
- Atrial fibrillation (I48.x) β HCC 226 β affects propranolol/beta-blocker treatment choice and DBS/MRgFUS eligibility (anticoagulation impacts surgical candidacy)
- Heart failure (I50.x) β HCC 225 β affects propranolol eligibility (contraindicated in decompensated HF)
- COPD (J44.1) β review HCC mapping β contraindication to propranolol (non-selective beta-blocker); requires primidone or alternative
- Diabetes mellitus (E11.x) β HCC 37 range β propranolol may mask hypoglycemia symptoms
- Anxiety disorders (F41.1) β highly prevalent in ET; tremor exacerbation by anxiety well-documented; propranolol may treat both
- Major depressive disorder (F32.9) β review HCC mapping β prevalent in ET due to social disability
- Dementia β when present alongside ET; query physician for severity and behavioral disturbance type
At every G25.0 encounter, complete UHDDS-compliant comorbidity coding generates the HCC capture that the ET code itself cannot.
π₯ MS-DRG Assignment
MDC 01 β Diseases and Disorders of the Nervous System
| DRG | Title | Est. Relative Weight* |
|---|---|---|
| DRG 056 | Degenerative Nervous System Disorders with MCC | ~2.23 |
| DRG 057 | Degenerative Nervous System Disorders without MCC | ~1.30 |
*Approximate. Verify against IPPS FY2026 Final Rule tables. Only two DRGs in this pair β no DRG 058. Note: inpatient admissions with G25.0 as principal for DBS or MRgFUS may group to surgical DRGs depending on the procedure code assigned β confirm with FY2026 GROUPER.
ET Inpatient Stays Are Typically Surgical β DRG 056/057 May Not Apply
Pure medical inpatient admissions with G25.0 as the principal diagnosis (without a surgical procedure) are uncommon. Most G25.0 inpatient stays occur for DBS implantation (61885/61886) or MRgFUS thalamotomy (61715) β in these cases, the surgical procedure determines the DRG assignment, which will typically be a neurosurgical DRG (e.g., DRG 023/025/026 range for craniotomy) rather than the medical DRG 056/057 pair. Confirm the actual DRG with the FY2026 GROUPER using the specific procedure code.
π Related ICD-10-CM Codes
G25 Tremor and Movement Disorder Family
| Code | Description | Clinical Distinction from G25.0 |
|---|---|---|
| R25.1 | Tremor, unspecified | Symptom code β pre-diagnosis; replaced by G25.0 once ET confirmed |
| G25.1 | Drug-induced tremor | Medication-caused tremor (valproate, lithium, SSRIs); requires T-code companion |
| G25.2 | Other specified forms of tremor | Intention tremor of cerebellar disease; NOT ET |
| G25.3 | Myoclonus | Rapid, jerky muscle contractions β not tremor |
| G25.81 | Restless legs syndrome | Separate movement disorder; may coexist with ET |
G20.x β Idiopathic PD Codes (Critical Distinction from G25.0)
| Code | Description | Tremor Type |
|---|---|---|
| G20.A1 | PD without dyskinesia, without fluctuations | REST tremor β NOT ET; Excludes1 from G25.0 |
| G20.A2 | PD without dyskinesia, with fluctuations | REST tremor β NOT ET |
| G20.B1 | PD with dyskinesia, without fluctuations | REST tremor β NOT ET |
| G20.B2 | PD with dyskinesia, with fluctuations | REST tremor β NOT ET |
Dystonia Codes (Excludes1 from G25 Category)
| Code | Description | Note |
|---|---|---|
| G24.3 | Spasmodic torticollis | Cervical dystonia; head tremor may be dystonic, not ET β physician must distinguish |
| G24.01 | Drug induced subacute dyskinesia | Drug-induced involuntary movements β not ET |
Common Comorbidity Codes at G25.0 Encounters
| Code | Description | Coding Relevance |
|---|---|---|
| I10 | Essential (primary) hypertension | Active comorbidity; propranolol prescribed for ET also manages HTN β document dual indication; code at every encounter |
| I48.20 | Chronic atrial fibrillation, unspecified | Affects DBS and MRgFUS surgical candidacy; propranolol/beta-blocker choice; HCC 226 |
| J44.1 | Chronic obstructive pulmonary disease with acute exacerbation | Propranolol contraindication β document COPD to support primidone/topiramate/alternative selection over propranolol |
| J44.9 | Chronic obstructive pulmonary disease, unspecified | Propranolol contraindication |
| F41.1 | Generalized anxiety disorder | Anxiety exacerbates ET; propranolol also used for performance/situational anxiety; document when present |
| F32.9 | Major depressive disorder, single episode, unspecified | Prevalent in ET due to functional disability and social embarrassment; code when documented and active |
| R26.89 | Other abnormalities of gait and mobility | If gait impairment documented as part of ET-plus (with cerebellar features) |
| Z96.82 | Presence of neurostimulator | Code when VIM DBS is already implanted for ET management |
| W19.XXXA | Unspecified fall, initial encounter | Falls from tremor-related instability; more common in ET-plus and lower limb ET involvement |
π οΈ Commonly Associated CPT Codes (Neurology / ENT)
Outpatient and Physician Setting Context
Essential tremor is primarily managed in outpatient neurology, movement disorders, and primary care settings. Advanced procedural therapies (DBS, MRgFUS, botulinum toxin) require specialist documentation of medication failure and functional impairment.
| CPT Code | Description | Clinical Application |
|---|---|---|
| 99204 | Office or other outpatient visit, new patient, moderate MDC | New patient evaluation for essential tremor β diagnosis establishment, differential diagnosis (ET vs. PD vs. physiologic), initiation of pharmacotherapy |
| 99205 | Office or other outpatient visit, new patient, high MDC | Complex new ET evaluation β multiple comorbidities affecting treatment choice, advanced therapy discussion (DBS/MRgFUS), extensive history of prior medication trials |
| 99214 | Office or other outpatient visit, established patient, moderate MDC | Follow-up ET management β medication adjustment, tremor severity assessment, fall risk, functional impact documentation |
| 99215 | Office or other outpatient visit, established patient, high MDC | Complex ET follow-up β DBS/MRgFUS candidacy evaluation, multiple failed pharmacotherapy trials documented, high comorbidity, caregiver involvement |
| 96116 | Neurobehavioral status exam; first hour | Cognitive screening at ET encounters β ET-plus may have mild cognitive features; distinguish from early PD dementia; screen for depression/anxiety in ET |
| 64617 | Chemodenervation of larynx, unilateral or bilateral, percutaneous (injection of laryngeal muscle) | Botulinum toxin injection for essential voice tremor β primary procedural treatment for disabling laryngeal ET; OnabotulinumtoxinA or RimabotulinumtoxinB into thyroarytenoid muscle |
| 64616 | Chemodenervation of muscle(s) innervated by facial nerve, unilateral | Botulinum toxin for ET head tremor affecting facial/perioral muscles β injected into neck muscles (splenius capitis, sternocleidomastoid) or perioral muscles |
| 64642 | Chemodenervation of one extremity; 1-4 muscles | Botulinum toxin for essential hand/forearm tremor β when tremor is disabling and DBS/MRgFUS is not indicated or declined; wrist extensors/flexors targeted |
| 64643 | +Chemodenervation of one extremity; each additional extremity, 1-4 muscles | Add-on for additional extremity botulinum toxin injection; never alone |
| 61715 | Stereotactic radiosurgical procedure (MRgFUS) β brain stem, cerebral hemisphere, or diencephalon; each additional stage | MRgFUS unilateral VIM thalamotomy for medication-refractory ET; FDA-approved; covered by Medicare and as of January 2026, NYS Medicaid; requires documentation of G25.0, medication failure, and functional disability |
| 61796 | Stereotactic radiosurgery; 1 simple lesion | Gamma Knife thalamotomy β VIM radiosurgical ablation for ET when DBS is contraindicated (anticoagulation, surgical risk); unilateral |
| 61885 | Insertion or replacement of cranial neurostimulator pulse generator; single electrode array | VIM DBS IPG implantation (unilateral) for ET β IPG implant/replacement for thalamic DBS; G25.0 supports medical necessity |
| 61886 | Insertion or replacement of cranial neurostimulator pulse generator; two or more electrode arrays | Bilateral VIM DBS IPG β bilateral thalamic DBS for bilateral disabling ET; unique to ET (PD DBS more commonly uses STN or GPi) |
| 95983 | Electronic analysis of implanted neurostimulator pulse generator/transmitter (DBS), programming; first 15 minutes | VIM DBS programming for ET β stimulation parameter optimization for tremor suppression |
| 95984 | +Electronic analysis of implanted neurostimulator pulse generator/transmitter (DBS), programming; each additional 15 minutes | Add-on for additional DBS programming time; never alone |
| 31575 | Laryngoscopy, flexible; diagnostic | Flexible laryngoscopy for visualization of vocal cord tremor β performed prior to botulinum toxin injection for essential voice tremor; documents vocal fold oscillation pattern; append modifier -26 if professional component only |
| 78607 | Brain imaging, tomographic (SPECT) | DaTscan β when ET vs. PD differential remains uncertain after clinical evaluation; normal DaTscan confirms ET (no dopaminergic deficit); abnormal β reclassify to G20.x; append modifier -26 for professional interpretation only |
NCCI Bundling Considerations
NCCI PTP Edits β Verify Before Billing
- 95983 and 95984 are bundled into 61885/61886 (DBS surgery) on the same DOS β do NOT report programming with implantation.
- 99214/99215 and 95983/95984 same DOS: modifier -25 required on the E/M when separately identifiable beyond the programming visit.
- 64617 (laryngeal chemodenervation) and 31575 (laryngoscopy) same DOS: verify NCCI PTP edit β laryngoscopy may be bundled into the injection procedure when performed as part of guidance; modifier -59 may be required with appropriate documentation if performed as a separately necessary diagnostic service.
- 64642 (extremity chemodenervation, 1-4 muscles) and 64617 (laryngeal chemodenervation) same DOS: verify NCCI bundling when treating both hand tremor AND voice tremor with botulinum toxin at the same encounter.
- 61715 (MRgFUS) β verify that facility and professional components are billed appropriately; typically a global or split-billing scenario.
- 78607 (DaTscan) professional component: modifier -26 for neurologist interpretation only; modifier -TC for facility; global if same provider performs and interprets.
π¬ ICD-10-PCS Crosswalk (Inpatient Procedures)
When G25.0 is an inpatient diagnosis and a surgical or therapeutic procedure is performed, the following ICD-10-PCS sections are relevant.
| PCS Section | Body System | Root Operation | Clinical Application |
|---|---|---|---|
| 0 (Medical & Surgical) | 0 (Central Nervous System) | H (Insertion) | 00H00MZ β DBS lead placement into brain (open approach); VIM thalamus is the target for ET DBS β distinct from GPi/STN targets used for PD |
| 0 (Medical & Surgical) | J (Subcutaneous Tissue) | H (Insertion) | 0JH60MZ β DBS IPG implantation into chest subcutaneous tissue and fascia |
| 0 (Medical & Surgical) | 0 (Central Nervous System) | W (Revision) | DBS lead revision or IPG replacement (battery change) |
| B (Imaging) | 3 (Central Nervous System) | 3 (MRI) | B030YZZ / B031YZZ β Brain MRI (pre-surgical planning for DBS or MRgFUS) |
| C (Nuclear Medicine) | 3 (Central Nervous System) | 1 (Planar Nuclear Medicine Imaging) | DaTscan SPECT β ET vs. PD differential; normal DaTscan confirms ET |
| D (Radiation Therapy) | 0 (Central Nervous System) | S (Stereotactic Radiosurgery) | D0023JZ β Stereotactic gamma beam radiosurgery, brain (Gamma Knife thalamotomy for ET when DBS not feasible) |
| G (Mental Health) | Z (None) | 3 (Psychological Tests) | GZ3ZZZZ β Neuropsychological testing (pre-DBS candidacy cognitive assessment; ET-plus cognitive profiling) |
π Coding Scenarios and Examples
Scenario 1 β New Patient, Essential Tremor Diagnosis Established, Propranolol Initiated (Outpatient)
Clinical Vignette: A 68-year-old female presents to neurology for bilateral hand tremor present for 5 years, worsening over the past year. Tremor occurs when holding objects and writing (kinetic and postural). Negative family history. No rest tremor. No bradykinesia, no rigidity. Neurological exam: bilateral 7 Hz postural and kinetic hand tremor, symmetric; no other abnormalities. Physician documents: βEssential tremor β bilateral action tremor of the hands, no features of Parkinsonβs disease. Initiating propranolol 40 mg BID.β
CPT Codes:
- 99204 β New patient office visit, moderate MDC (new diagnosis, pharmacotherapy initiation)
ICD-10-CM:
- G25.0 β Essential tremor
Document Functional Impact for Medical Necessity
Documentation such as βunable to hold cup steadily,β βdifficulty writing checks,β or βimpaired handwritingβ directly supports the medical necessity of pharmacotherapy and, if progression occurs, advanced therapy. Functional impact language is required for DBS and MRgFUS prior authorization and should be established from the first ET encounter.
Scenario 2 β Medication-Refractory ET, MRgFUS Candidacy Evaluation (Outpatient)
Clinical Vignette: A 72-year-old male with a 10-year history of essential tremor affecting the right hand predominantly reports that propranolol and primidone both failed to provide adequate tremor control and are not tolerated due to fatigue and dizziness. Tremor is severe β unable to feed himself. Physician documents: βMedication-refractory essential tremor, two first-line agents failed. Evaluating for MRgFUS candidacy.β
CPT Codes:
- 99215 β Established patient, high MDC (medication failure documentation, advanced therapy candidacy evaluation, complex decision-making)
ICD-10-CM:
- G25.0 β Essential tremor
Document Both Prior Medication Failures for MRgFUS/DBS Coverage
Medicare and commercial payers require documented failure of AT LEAST TWO pharmacological agents (typically propranolol and primidone as first-line) before covering MRgFUS (61715) or DBS (61885/61886) for ET. The neurology note must explicitly state the agents trialed, the doses, and the reason for failure (lack of efficacy vs. adverse effect). G25.0 as the sole supported ICD-10-CM code for these advanced procedures β there is no other ET-specific ICD code; specificity and severity must come from the documentation, not from an additional code.
Scenario 3 β Essential Voice Tremor, Botulinum Toxin Injection (Outpatient ENT/Neurology)
Clinical Vignette: A 65-year-old female with essential tremor involving the voice for 3 years presents for botulinum toxin injection. She reports a tremulous, quavering voice that significantly impairs professional communication. Prior propranolol trial failed. Flexible laryngoscopy confirms bilateral vocal fold tremor. OnabotulinumtoxinA injected bilaterally into the thyroarytenoid muscles under EMG guidance.
CPT Codes:
- 99213 β Established patient, low MDC (medication management, injection planning); append modifier -25
- 31575 β Laryngoscopy, flexible; diagnostic (pre-injection visualization β verify NCCI bundling; modifier -59 may apply if performed as a separately necessary service)
- 64617 β Chemodenervation of larynx, unilateral or bilateral (botulinum toxin injection β bilateral thyroarytenoid)
ICD-10-CM:
- G25.0 β Essential tremor (essential voice tremor β Familial tremor Includes term covers all body regions)
Scenario 4 β VIM DBS Programming, ET, Existing DBS (Outpatient)
Clinical Vignette: A 70-year-old male with essential tremor, status post bilateral VIM DBS implantation 1 year ago, presents for DBS programming. Residual tremor on the left side. Programming session takes 30 minutes. Separately identifiable E/M performed for review of propranolol continuation and blood pressure.
CPT Codes:
- 99213 β Established patient, low MDC; append modifier -25
- 95983 β DBS programming, first 15 minutes
- 95984 β +DBS programming, additional 15 minutes (Γ1)
ICD-10-CM:
- G25.0 β Essential tremor
- Z96.82 β Presence of neurostimulator (existing bilateral VIM DBS)
- I10 β Essential hypertension (active, treated β propranolol dual-purpose; code at every encounter)
Scenario 5 β ET vs. PD Differential β DaTscan Ordered (Outpatient)
Clinical Vignette: A 75-year-old female presents with bilateral hand tremor and some rest component noted on exam. Physician is uncertain whether this is ET or early PD. Documents: βTremor β differential: essential tremor vs. early Parkinsonβs disease. DaTscan ordered.β DaTscan result available at follow-up: NORMAL.
At Initial Visit:
- CPT: 99205 β New patient, high MDC (complex differential, advanced workup planning); 78607 ordered but not yet resulted
- ICD-10-CM: R25.1 β Tremor, unspecified (diagnosis not yet confirmed β use symptom code)
At Follow-Up After Normal DaTscan:
- CPT: 99214 β Established patient, moderate MDC (DaTscan result review, ET diagnosis established, treatment initiation); 78607 with modifier -26 (if neurologist interprets DaTscan at this encounter)
- ICD-10-CM: G25.0 β Essential tremor (normal DaTscan confirms ET; R25.1 is now replaced by G25.0)
Normal DaTscan = Replace R25.1 With G25.0
A normal DaTscan result β confirming intact dopamine transporter uptake β effectively rules out dopaminergic neurodegeneration (idiopathic PD, PSP, MSA) and is one of the most powerful diagnostic tools for confirming G25.0 over G20.x. Once the normal DaTscan result is documented alongside the physicianβs clinical ET diagnosis, R25.1 is retired and G25.0 should be assigned at all subsequent encounters.
β οΈ Coding Pitfalls and Tips
| Pitfall or Tip | |
|---|---|
| β | Never assign G25.0 and R25.1 simultaneously β Excludes1; once ET is documented, G25.0 replaces R25.1; they are mutually exclusive at the same encounter |
| β | Never code the resting tremor of Parkinsonβs disease as G25.0 β PD rest tremor is not essential tremor; it is a cardinal PD symptom coded within the G20.x subcodes; assigning G25.0 for PD tremor is a coding error |
| β | Never assign G25.0 without physician documentation of βessential tremorβ β symptom documentation alone (bilateral tremor, postural tremor) is not sufficient; the physician must state the diagnosis; use R25.1 until ET is confirmed and documented |
| β | Never use G25.0 to support DBS or MRgFUS without documenting medication failure β both procedures require documented failure of at least two pharmacological agents; G25.0 establishes the diagnosis but the note must document treatment history for prior authorization |
| β | Never confuse essential tremor with dystonic tremor β head tremor or hand tremor with dystonic posturing is NOT G25.0; query physician for ET vs. dystonic tremor distinction; dystonic tremor maps to G24.x |
| β | Never omit the DaTscan result in documentation β a normal DaTscan is one of the most important diagnostic anchors for G25.0; document it explicitly to distinguish from PD |
| β | Do not assign G25.0 with a G20.x code unless the physician explicitly documents both ET and PD as separately coexisting (ET-PD overlap) β when both are documented as coexisting distinct conditions, both may be coded; when documentation is ambiguous, issue a CDI query |
| β | Document functional impact at every ET encounter β βunable to eat independently,β βimpaired handwriting,β βsocially withdrawn due to tremor visibilityβ β this language is required for advanced therapy prior authorization and reflects higher E/M complexity |
| β | Document alcohol responsiveness when reported β βtremor improves with 1-2 drinksβ is a highly specific ET confirmatory feature; add to the note to strengthen the clinical diagnosis record |
| β | Code propranolol-related comorbidities β I10 (HTN), J44.9 (COPD β contraindication), I48.x (AF β rate control context) are all active comorbidities that should be coded at every encounter when documented and managed |
| β | Code anxiety (F41.1) when documented β anxiety exacerbates ET; propranolol may treat both; documenting this dual indication supports prescribing decisions and generates HCC-bearing diagnosis coding |
| β | G25.0 supports both VIM DBS (61885/61886) AND MRgFUS (61715) β these are the two primary surgical procedures for ET; G25.0 is the necessary and sufficient ICD-10-CM code for both; ensure it is correctly documented in every surgical and prior auth record |
| β | Code Z96.82 (presence of neurostimulator) when VIM DBS is already implanted β supports programming CPT codes 95983/95984 at follow-up visits |
| β | For essential voice tremor β ensure 64617 is supported by laryngoscopy findings β documentation of vocal fold tremor on flexible laryngoscopy (31575) is the standard pre-injection assessment and strengthens medical necessity for botulinum toxin chemodenervation |
π Sources
-
CMS/NCHS. ICD-10-CM Official Guidelines for Coding and Reporting, FY2026. Tabular List β G25.0 (Essential tremor, Familial tremor Includes); Excludes1 (tremor NOS β R25.1); G25 category structure.
-
Pabau. ICD-10-CM Tremor Codes: R25.1, G25.0, G25.1, G25.2. March 2026. Code selection algorithm; G25.0 vs. R25.1 transition criteria; drug-induced tremor distinction.
-
StatPearls/NCBI. Essential Tremor. NBK499986. Updated July 2023. Bilateral 6-12 Hz action tremor; 50-70% familial; autosomal dominant; clinical diagnostic criteria; alcohol responsiveness.
-
Medscape. Essential Tremor: Background, Diagnostic Criteria, Epidemiology. Updated January 2024. Prevalence 5-10% over age 60; pathophysiology; genetics; diagnostic criteria.
-
PMC/NIH. Distinguishing Essential Tremor from Parkinsonβs Disease. PMC3475963. Rest vs. action tremor; DaTscan; clinical differentiation.
-
PMC/NIH. Validation of ICD-10-CM Code G25.0 for ET. PMC11225552. July 2024. Improved ET case identification with ICD-10-CM G25.0 vs. prior coding.
-
ScienceDirect. Familial versus Sporadic Essential Tremor β Prospective Cohort. November 2023. Age of onset differences; familial vs. sporadic ET clinical evolution.
-
CMS. Billing and Coding: MRI-Guided High Intensity Focused Ultrasound Surgery (MRgFUS) for Essential Tremor and Tremor Dominant Parkinsonβs Disease. Article ID 57513. CPT 61715; coverage criteria; documentation requirements.
-
MetroPlusHealth / NYS Medicaid. Coverage of MRgFUS for Essential Tremor. Effective January 1, 2026. CPT 61715; medication-refractory ET coverage criteria.
-
Blue Shield California. Medical Policy 7.01.63 β Deep Brain Stimulation. DBS for disabling medication-refractory ET; thalamic VIM target; CPT 61885/61886/95983/95984.
-
AAPC Codify. ICD-10 Code G25.0 β Essential Tremor. G25 category structure; Excludes1 cross-references.
-
CMS. IPPS Final Rule FY2026 β MS-DRG Definitions Manual v43. MDC 01; DRG 056/057.
-
CMS. 2026 Medicare Advantage CMS-HCC Model v28 β Final Risk Adjustment Coefficients. Confirmation G25.0 not mapped to HCC v28.
-
AMA. CPT Professional Edition 2026. Neurology; chemodenervation codes; DBS; MRgFUS; laryngoscopy; E/M guidelines.
-
CMS. NCCI Policy Manual for Medicare Services, current version.
Crystal's Coder Hub